{"entity":{"type":"insider","cik":"0001816134","url":"/insider/0001816134","json_url":"/insider/0001816134.json","name":"EcoR1 Panacea Holdings, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":2,"first":"2020-07-06","last":"2021-04-13","span_basis":"filed_date"},"name_variants":[{"name":"EcoR1 Panacea Holdings, LLC","source":"filing","n_filings":2,"first_seen":"2020-07-06","last_seen":"2021-04-13"}],"transactions":[{"id":4147182,"accession":"0001567619-21-007976","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-21-007976","line_url":"/filing/0001567619-21-007976","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Panacea Holdings, LLC; Biotech Opportunity GP, LLC; EcoR1 Capital, LLC; EcoR1 Capital Fund, L.P.; EcoR1 Venture Opportunity Fund, LP; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG","owner_display_name":"EcoR1 Panacea Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31500.0,"shares_display":"31,500","price_per_share":10.271,"price_display":"10.27","price_state":"stated","total_value":323536.5,"total_display":"323,536.50","total_whole":"323,537","shares_owned_after":6990265.0,"shares_owned_after_display":"6,990,265","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-13","scope":"insider","n_lines":2},{"id":4147177,"accession":"0001567619-21-007976","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-21-007976","line_url":"/filing/0001567619-21-007976","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Panacea Holdings, LLC; Biotech Opportunity GP, LLC; EcoR1 Capital, LLC; EcoR1 Capital Fund, L.P.; EcoR1 Venture Opportunity Fund, LP; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG","owner_display_name":"EcoR1 Panacea Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133000.0,"shares_display":"133,000","price_per_share":9.4878,"price_display":"9.49","price_state":"stated","total_value":1261877.4,"total_display":"1,261,877.40","total_whole":"1,261,877","shares_owned_after":6962731.0,"shares_owned_after_display":"6,962,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-13","scope":"insider","n_lines":2},{"id":4147169,"accession":"0001567619-21-007976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-007976","line_url":"/filing/0001567619-21-007976","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Panacea Holdings, LLC; Biotech Opportunity GP, LLC; EcoR1 Capital, LLC; EcoR1 Capital Fund, L.P.; EcoR1 Venture Opportunity Fund, LP; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG","owner_display_name":"EcoR1 Panacea Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":10.0306,"price_display":"10.03","price_state":"stated","total_value":3009180.0,"total_display":"3,009,180.00","total_whole":"3,009,180","shares_owned_after":6846476.0,"shares_owned_after_display":"6,846,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-09","filed_date":"2021-04-13","scope":"insider","n_lines":2},{"id":3048705,"accession":"0001213900-20-016762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-20-016762","line_url":"/filing/0001213900-20-016762#line-1","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Panacea Acquisition Corp","issuer_ticker":"PANA","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Panacea Holdings, LLC; EcoR1 Capital Fund, L.P.; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Venture Opportunity Fund, LP; EcoR1 Capital, LLC; Biotech Opportunity GP, LLC; NODELMAN OLEG","owner_display_name":"EcoR1 Panacea Holdings, LLC","owner_url":null,"role":"Director, Officer (CEO and Chairman of the Board), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":"CEO and Chairman of the Board","security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":390000.0,"shares_display":"390,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3900000.0,"total_display":"3,900,000.00","total_whole":"3,900,000","shares_owned_after":390000.0,"shares_owned_after_display":"390,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-06","filed_date":"2020-07-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001811063","name":"Nuvation Bio Inc.","url":"/issuer/0001811063","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2020-07-06","last_seen":"2021-04-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001816134","retrieved_at":"2026-08-25T18:21:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}